|
ANAB AnaptysBio Inc 1370053 |
| Balance Sheet |
|
Current Assets
|
$316,109,000.00 |
|
Assets
|
$329,684,000.00 |
|
Current Liabilities
|
$41,702,000.00 |
|
Equity
|
$12,747,000.00 |
|
Shares Out
|
29030784.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-25,919,000.00 |
|
Investing Cash Flow
|
$34,983,000.00 |
| Market Analysis |
Market Cap
|
$1,597,854,351.36 |
|
Price
|
$52.04 |
|
BVPS
|
0.44 |
|
PB
|
125.09 |
|
EPS
|
-1.84 |
|
PS
|
18.01 |
|
FCF
|
$-25,936,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Apr |
May |
Jun |
| 2026-03-03 |
1.58 |
|
|
2026-05-12 |
-1.84 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-1.34 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
0.52 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ANAB documents filed with the SEC.
ANAB Filings
Clear
